Table of Contents

2019-2024 Global Biologics and Biosimilars Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics and Biosimilars Consumption 2014-2024
2.1.2 Biologics and Biosimilars Consumption CAGR by Region
2.2 Biologics and Biosimilars Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Other
2.3 Biologics and Biosimilars Consumption by Type
2.3.1 Global Biologics and Biosimilars Consumption Market Share by Type (2014-2019)
2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biologics and Biosimilars Sale Price by Type (2014-2019)
2.4 Biologics and Biosimilars Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Other
2.5 Biologics and Biosimilars Consumption by Application
2.5.1 Global Biologics and Biosimilars Consumption Market Share by Application (2014-2019)
2.5.2 Global Biologics and Biosimilars Value and Market Share by Application (2014-2019)
2.5.3 Global Biologics and Biosimilars Sale Price by Application (2014-2019)

3 Global Biologics and Biosimilars by Players
3.1 Global Biologics and Biosimilars Sales Market Share by Players
3.1.1 Global Biologics and Biosimilars Sales by Players (2017-2019)
3.1.2 Global Biologics and Biosimilars Sales Market Share by Players (2017-2019)
3.2 Global Biologics and Biosimilars Revenue Market Share by Players
3.2.1 Global Biologics and Biosimilars Revenue by Players (2017-2019)
3.2.2 Global Biologics and Biosimilars Revenue Market Share by Players (2017-2019)
3.3 Global Biologics and Biosimilars Sale Price by Players
3.4 Global Biologics and Biosimilars Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biologics and Biosimilars Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biologics and Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Biologics and Biosimilars by Regions
4.1 Biologics and Biosimilars by Regions
4.1.1 Global Biologics and Biosimilars Consumption by Regions
4.1.2 Global Biologics and Biosimilars Value by Regions
4.2 Americas Biologics and Biosimilars Consumption Growth
4.3 APAC Biologics and Biosimilars Consumption Growth
4.4 Europe Biologics and Biosimilars Consumption Growth
4.5 Middle East & Africa Biologics and Biosimilars Consumption Growth

5 Americas
5.1 Americas Biologics and Biosimilars Consumption by Countries
5.1.1 Americas Biologics and Biosimilars Consumption by Countries (2014-2019)
5.1.2 Americas Biologics and Biosimilars Value by Countries (2014-2019)
5.2 Americas Biologics and Biosimilars Consumption by Type
5.3 Americas Biologics and Biosimilars Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biologics and Biosimilars Consumption by Countries
6.1.1 APAC Biologics and Biosimilars Consumption by Countries (2014-2019)
6.1.2 APAC Biologics and Biosimilars Value by Countries (2014-2019)
6.2 APAC Biologics and Biosimilars Consumption by Type
6.3 APAC Biologics and Biosimilars Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Biologics and Biosimilars by Countries
7.1.1 Europe Biologics and Biosimilars Consumption by Countries (2014-2019)
7.1.2 Europe Biologics and Biosimilars Value by Countries (2014-2019)
7.2 Europe Biologics and Biosimilars Consumption by Type
7.3 Europe Biologics and Biosimilars Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Biologics and Biosimilars by Countries
8.1.1 Middle East & Africa Biologics and Biosimilars Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Biologics and Biosimilars Value by Countries (2014-2019)
8.2 Middle East & Africa Biologics and Biosimilars Consumption by Type
8.3 Middle East & Africa Biologics and Biosimilars Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biologics and Biosimilars Distributors
10.3 Biologics and Biosimilars Customer

11 Global Biologics and Biosimilars Market Forecast
11.1 Global Biologics and Biosimilars Consumption Forecast (2019-2024)
11.2 Global Biologics and Biosimilars Forecast by Regions
11.2.1 Global Biologics and Biosimilars Forecast by Regions (2019-2024)
11.2.2 Global Biologics and Biosimilars Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biologics and Biosimilars Forecast by Type
11.8 Global Biologics and Biosimilars Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Company Details
12.1.2 Biologics and Biosimilars Product Offered
12.1.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Roche News
12.2 Amgen
12.2.1 Company Details
12.2.2 Biologics and Biosimilars Product Offered
12.2.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Amgen News
12.3 AbbVie
12.3.1 Company Details
12.3.2 Biologics and Biosimilars Product Offered
12.3.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 AbbVie News
12.4 Sanofi-Aventis
12.4.1 Company Details
12.4.2 Biologics and Biosimilars Product Offered
12.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sanofi-Aventis News
12.5 Johnson & Johnson
12.5.1 Company Details
12.5.2 Biologics and Biosimilars Product Offered
12.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson News
12.6 Pfizer
12.6.1 Company Details
12.6.2 Biologics and Biosimilars Product Offered
12.6.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Pfizer News
12.7 Novo Nordisk
12.7.1 Company Details
12.7.2 Biologics and Biosimilars Product Offered
12.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Novo Nordisk News
12.8 Eli Lilly
12.8.1 Company Details
12.8.2 Biologics and Biosimilars Product Offered
12.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Eli Lilly News
12.9 Novartis
12.9.1 Company Details
12.9.2 Biologics and Biosimilars Product Offered
12.9.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Novartis News
12.10 Merck
12.10.1 Company Details
12.10.2 Biologics and Biosimilars Product Offered
12.10.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Merck News
12.11 3sbio
12.12 Changchun High Tech
12.13 CP Guojian
12.14 Biotech
12.15 Gelgen
12.16 Innovent
12.17 Dong Bao
12.18 Ganlee

13 Research Findings and Conclusion